Atlas Trials

Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers

Clinical trial NCT00992069 · COMPLETED

Trial details

NCT number
NCT00992069
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
TuberculosisHIV
Start date
2009-12-01
Primary completion
2010-12-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.